MAsS Scan as a Predictor of Morbidity and Mortality in Patients With Liver Disease

Recruiting now

Conditions studied: Liver Diseases

In brief

The purpose of the study is to study the muscle assessment score (MAsS, utilizing MRI, as an objective measure of frailty and muscle composition to serve as a predictor of morbidity and mortality in patients with liver disease.

Key facts

Study ID

NCT05264051

Run by

University of Chicago

People needed

1200

Starts

2022-04-18

Expected to finish

2027-03-01

Last updated by the study team

2026-01-14

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients who are already scheduled for an MRI for routine clinical purposes will be evaluated

You may not qualify if…

• <18 yrs. of age

Where it is running

• The University of Chicago — Chicago, Illinois, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.